FDA Approved First Drug to Treat Progeria

The U.S. Food and Drug Administration (FDA) has approved Zokinvy (lonafarnib) to treat progeria, a rare disease often known as the advanced aging disease. More specifically, the FDA has approved lonafarnib capsules to reduce the risk of death due to Hutchinson-Gilford...

Parents’ Hopes for New Rett Syndrome Treatments

  Molly and Adam Fleming, the parents of Natalie, a young girl with Rett Syndrome, discuss the treatment landscape for Rett and their hopes for future treatments. Rett Syndrome is a rare progressive neurodevelopmental condition that primarily affects girls. These...

Treating AADC Deficiency

  Irina Anselm, MD, from Boston Children’s Hospital provides an overview of treatment options for aromatic L-amino acid decarboxylase (AADC) deficiency. AADC deficiency is a rare neurodegenerative disease caused by a defect in the dopa decarboxylase (DDC) gene...